
Adults with AChR antibody–positive generalized myasthenia gravis now have a C5 inhibitor they can inject themselves at home once a week.
In episode 9, Suzanne Soliman, PharmD, BCMAS, discussed pharmacogenomics with 3 special guests.
In episode 9, Suzanne Soliman, PharmD, BCMAS, sat down with guest speakers Jamie Wilkey, PharmD, RPh; Ani Rostomyan, PharmD, BCPS; and Bhavana Mutha, RPh, BCMAS, BCMTMS, PDTM, to discuss pharmacogenomics.





